Moolec Science (MLEC) Other Non-Current Liabilities (2022 - 2026)
Moolec Science's (MLEC) quarterly Other Non-Current Liabilities came in at $300000.0 in Q1 2026, up 71.12% quarter-over-quarter from $175316.0 in Q4 2025.
Moolec Science (MLEC) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
Moolec Science has disclosed Other Non-Current Liabilities across 5 years of filings, most recently posting $300000.0 for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $300000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $300000.0 (changed N/A YoY), and the FY2025 annual result was $16.2 million, down 7.61% from the prior year.
- Other Non-Current Liabilities came in at $300000.0 for Q1 2026 at Moolec Science, up from $175316.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $17.5 million in Q2 2024 to a low of -$184933.0 in Q3 2024.
- The 5-year median for Other Non-Current Liabilities is $494578.0 (2024), against an average of $2.7 million.
- Across the five-year window, Other Non-Current Liabilities surged 143849.19% in 2023 and slumped 110.05% in 2024, its largest moves.
- Moolec Science's Other Non-Current Liabilities stood at $836946.0 in 2022, then plunged by 87.48% to $104766.0 in 2023, then jumped by 372.08% to $494578.0 in 2024, then sank by 64.55% to $175316.0 in 2025, then jumped by 71.12% to $300000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $300000.0 (Q1 2026), $175316.0 (Q4 2025), and $16.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 175,316.00 |
| Jun 30, 2025 | 16.15 Mn |
| Dec 31, 2024 | 494,578.00 |
| Sep 30, 2024 | -184,933.00 |
| Jun 30, 2024 | 17.48 Mn |
| Mar 31, 2024 | -81,471.00 |
| Dec 31, 2023 | 104,766.00 |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 869,946.00 |
| Dec 31, 2022 | 836,946.00 |
| Sep 30, 2022 | 621,727.00 |
| Jun 30, 2022 | 1,171.00 |
| Mar 31, 2022 | 1,682.00 |